TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shionogi & Co ( (JP:4507) ) just unveiled an update.
Shionogi & Co., Ltd. announced the successful completion of its tender offer for shares of Torii Pharmaceutical Co., Ltd., which will become an equity-method affiliate of Shionogi as of June 25, 2025. This acquisition is expected to enhance Shionogi’s market position and expand its influence in the pharmaceutical industry, potentially impacting stakeholders by increasing the company’s operational scope and strategic capabilities.
The most recent analyst rating on (JP:4507) stock is a Hold with a Yen2750.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its work in the healthcare industry, particularly in creating medications and treatments for various diseases.
Average Trading Volume: 2,593,191
Technical Sentiment Signal: Buy
Current Market Cap: Yen2206.3B
For a thorough assessment of 4507 stock, go to TipRanks’ Stock Analysis page.